Hepatology Acceptance Rate

At triage, the editor is usually asking:

• does this study advance understanding or management of a liver disease?
• is the evidence strong enough — large cohorts, mechanistic depth, or clinical validation?
• does the work address a question the hepatology community considers important now?
• would this paper change clinical practice, disease classification, or treatment approaches?

Papers that address a clinically relevant liver-disease question with strong evidence will survive triage more reliably than technically sound studies without clear disease implications.

For Hepatology, the useful question is:

Does this study advance liver-disease science in a way that the AASLD community would consider significant?

If yes, the journal is a strong fit. If the paper is a basic science study where the liver connection is peripheral, or a clinical observation without practice-changing implications, the acceptance rate is not the constraint. The disease significance is.

The common misses are:

• centering strategy around an unofficial percentage instead of checking liver-disease significance
• submitting GI work that happens to include liver data without the liver being the central question
• presenting animal model results without connecting them to human liver disease
• ignoring Journal of Hepatology (EASL flagship) as the direct competitor and alternative
• treating Hepatology Communications as a lesser journal rather than a realistic landing spot for sound work

Those are significance and scope problems before they are rate problems.

If you are deciding whether to submit, these pages are more useful than an unofficial rate:

• Hepatology cover letter
• Hepatology submission process
• Hepatology submission guide
• Gastroenterology acceptance rate (for broader GI work)
• Gut acceptance rate (for GI work with liver overlap)

Together, they tell you whether the paper has enough liver-disease significance, whether the editorial timeline is manageable, and whether a different hepatology venue would be a cleaner first submission.

The honest answer to "what is the Hepatology acceptance rate?" is that AASLD does not publish one, and third-party estimates around 15% should be treated as approximate.

The useful answer is:

• yes, this is the AASLD flagship and a selective liver journal
• no, a guessed percentage is not the right planning tool
• use liver-disease significance, clinical relevance, and AASLD-community importance as the real filter instead

If you want help pressure-testing whether this manuscript is positioned for a Hepatology submission before upload, a free Manusights scan is the best next step.